Recently we reported a nanocontainer based reduction triggered release system through an engineered transmembrane channel (FhuA Δ1-160; Onaca
In total, 12 FhuA Δ1-160 variants were generated to gain insights on sterically controlled compound fluxes: Subset A) six FhuA Δ1-160 variants in which one of the six lysines in the interior of FhuA Δ1-160 was substituted to alanine and Subset B) six FhuA Δ1-160 variants in which only one lysine inside the barrel was not changed to alanine. Translocation efficiencies were quantified with the colorimetric TMB (3,3',5,5'-tetramethylbenzidine) detection system employing horseradish peroxidase (HRP). Investigation of the six subset A variants identified position K556A as sterically important. The K556A substitution increases TMB diffusion from 15 to 97 [nM]/s and reaches nearly the TMB diffusion value of the unlabeled FhuA Δ1-160 (102 [nM]/s). The prominent role of position K556 is confirmed by the corresponding subset B variant which contains only the K556 lysine in the interior of the barrel. Pyridyl labeling of K556 reduces TMB translocation to 16 [nM]/s reaching nearly background levels in liposomes (13 [nM]/s). A first B-factor analysis based on MD simulations confirmed that position K556 is the least fluctuating lysine among the six in the channel interior of FhuA Δ1-160 and therefore well suited for controlling compound fluxes through steric hindrance.
A FhuA Δ1-160 based reduction triggered release system has been shown to control the compound flux by the presence of only one inner channel sterical hindrance based on 3-(2-pyridyldithio)propionic-acid labeling (amino acid position K556). As a consequence, the release kinetic can be modulated by introducing an opportune number of hindrances. The FhuA Δ1-160 channel embedded in liposomes can be advanced to a universal and compound independent release system which allows a size selective compound release through rationally re-engineered channels.
A channel protein that is embedded in an impermeable membrane offers the possibility to develop novel triggered drug release systems with potential applications in synthetic biology (pathway engineering), and medicine (drug release). So far only FhuA [
FhuA is a large monomeric transmembrane protein of 714 amino acids located in the
An average of four lysine residues per FhuA Δ1-160 was determined to be pyridyl labeled [
However, the better kinetic results reproducibility using liposomes compared to polymersomes, where the FhuA Δ1-160 insertion can be affected by block co-polymer poly-dispersity and traces of residual chemicals, suggested us to use liposomes correcting the kinetic results by the small leakage contribution (see Table
Average TMB conversions in liposomes.
| FhuA Δ1-160 variant reconstituted in liposomes | TMB conversion [nM]/s | *True averaged TMB conversion [nM]/s | **TMB conversion ratio | ||
|---|---|---|---|---|---|
|
|
Lacking FhuA Δ1-160 | - | 13 ± 2 | - | 1 |
|
|
|||||
| Unlabeled FhuA Δ1-160 | - | 102 ± 5 | 89 | 7.9 | |
|
|
|||||
| Fully labeled FhuA Δ1-160 starting variant | - | 15 ± 4 | 2 | 1.2 | |
|
|
|||||
|
|
K167A | 167 | 59 ± 2 | 46 | 4.5 |
|
|
|||||
| K344A | 344 | 52 ± 1 | 39 | 4 | |
|
|
|||||
| K364A | 364 | 20 ± 3 | 7 | 1.5 | |
|
|
|||||
| K537A | 537 | 76 ± 3 | 63 | 5.9 | |
|
|
|||||
| K556A | 556 | 97 ± 4 | 84 | 7.5 | |
|
|
|||||
| K586A | 586 | 14 ± 1 | 1 | 1.1 | |
|
|
|||||
|
|
K167 | 344, 364, 537, 556, 586 | 22 ± 2 | 9 | 1.7 |
|
|
|||||
| K344 | 167, 364, 537, 556, 586 | 23 ± 1 | 10 | 1.8 | |
|
|
|||||
| K364 | 167, 344, 537, 556, 586 | 30 ± 3 | 17 | 2.3 | |
|
|
|||||
| K537 | 167, 344, 364, 556, 586 | 21 ± 3 | 8 | 1.6 | |
|
|
|||||
| K556 | 167, 344, 364, 537, 586 | 16 ± 1 | 3 | 1.2 | |
|
|
|||||
| K586 | 167, 344, 364, 537, 556 | 35 ± 2 | 22 | 2.7 | |
Lambert Beer law was used with an extinction coefficient of 3.9 × 10-4 M-1 cm-1 for the first TMB oxidation product. Two subsets (A & B) of FhuA Δ1-160 variants were apart from controls analyzed. FhuA Δ1-160 variants of subset A contain a single lysine to alanine substitution while subset B contain five lysine to alanine substitutions. All FhuA Δ1-160 variants are pyridyl-labeled except two controls (liposome lacking FhuA Δ1-160 and the unlabeled FhuA Δ1-160). "*": The true TMB conversion is calculated from the TMB-conversion of FhuA Δ1-160 variant subtracted by the TMB conversion of the background lacking FhuA Δ1-160; "**": TMB conversion ratio represents a ratio between TMB conversions of pyridyl-labeled FhuA Δ1-160 variants and the liposome control lacking FhuA Δ1-160.
Figure
TMB as chromogen has been developed and widely used in enzyme immunoassays (EIA) employing horseradish peroxidase [
The HRP/TMB detection system is based on a two step consecutive oxidative reactions A→B→C (A = TMB; B and C = first and second TMB oxidation products, see Figure
Figure
HRP has been entrapped in the liposome harboring FhuA Δ1-160 variants by using film hydration method coupled with extrusion. In this method, the lipid amphiphile is brought in contact with the aqueous medium containing HRP and FhuA Δ1-160 in its dry state and is subsequently hydrated to yield vesicles. After homogenization and purification of the resultant liposomes, the TMB conversion was initiated by supplementing TMB (10 μl) to the aqueous solution. Background conversions of TMB due to liposome instabilities or translocation through the membrane in absence of FhuA Δ1-160 were determined to be 13 [nM]/s (Table
The aa-position 556 has a major impact on TMB conversion: K556A substitution increases TMB conversion to 97 [nM]/s which is close to the value of the FhuA Δ1-160 unlabeled variant. A further TMB important blocking position is found by the substitution K537A increasing TMB conversion to 76 [nM]/s. In summary the following order of increased TMB conversion has been observed for subset A variants: 586 < 364 < 344 < 167 < 537 < 556.
Subset B variants of FhuA Δ1-160 have in the inner channel only one labeled pyridyl-lysine. For pyridylated position 556, a reduction of the translocation to 16 [nM]/s was achieved. The latter proves impressively that a single labeled lysine can efficiently and independently from all other labeled lysines block TMB translocation through FhuA Δ1-160. For position 537 a cooperative effect can be observed since the subset B variant shows a significantly less pronounced TMB blocking as expected from the corresponding subset A variant. Similar to the subset A) variants the following increased TMB conversion has been observed for the subset B variants: 586 > 364 > 344 > 167 > 537 > 556.
Differences in the absolute values between the two experimental data sets can likely be attributed to pyridyl labeling efficiencies,
A working hypothesis for controlling the compound flux in the inner FhuA Δ1-160 precisely is a defined and rigid conformation of the blocking lysine residue. Lysine fluctuations of all six FhuA Δ1-160 have been directly correlated to the B factors deduced from Molecular Dynamics MD trajectories in a first simulation (see Additional file
In detail, FhuA Δ1-160 is a β-barrel with a cross-section of 39 Å and 46 Å on the "top" part and a reduced cross-section on the "lower" exit of the barrel, 29 Å and 19 Å. K556 is placed in a rigid β-barrel at the "lower" cross-section (Figure
In summary, experimental results and first computational simulations indicate that the rigidity of the labeled positions play an important role in generating FhuA Δ1-160 channels with a defined and "non-fluctuating" pore size. Fluctuations in pore sizes of FhuA Δ1-160 will reduce the discriminating power to control compound fluxes and are therefore an important prerequisite for a universal compound release system that can rapidly be re-engineered to match the compound size. Following up computational simulations are required to investigate in detail the roles of the pyridyl-label, to investigate cooperative effects of labeled lysine residues and taking labeling efficiency and perturbations of protein structure after labeling into account. Further FhuA Δ1-160 engineering efforts will be based on subset B) variant K556 to further advance the control of compound fluxes through the FhuA Δ1-160 channel, especially for low molecular weight compounds.
Molecular understanding of the sterically controlled diffusion in FhuA Δ1-160's inner channel is an important prerequisite to develop a universal compound release system that can rapidly be re-engineered for a "time and dose-dependent" compound release.
Six lysine residues were systematically analyzed in two subsets of engineered FhuA Δ1-160 channels. Analysis of 12 variants identified position K556 as a key substitution to sterically control compound fluxes through the inner channel of FhuA Δ1-160 embedded in liposome membrane. A first B-factor analysis based on MD simulations identified position K556 as the least fluctuating lysine among the six investigated lysines suggesting a correlation between flexibility and steric control of TMB compound translocation through the inner FhuA Δ1-160 channel. The subset B variant K556 of FhuA Δ1-160 represents therefore an excellent starting point to understand channel dynamics and to sterically control compound flux through engineered FhuA Δ1-160. Based on these results it seems promising that the reduction triggered release system can be advanced to a universal and compound independent release system which allows a size selective compound release through rationally re-engineered FhuA Δ1-160 channels.
All chemicals used were of analytical reagent grade or higher quality, purchased from Sigma-Aldrich Chemie (Taufkirchen, Germany) and Applichem (Darmstadt, Germany) if not stated otherwise. A thermal cycler (Mastercycler gradient; Eppendorf, Hamburg, Germany) and thin-wall PCR tubes (Mμlti-ultra tubes; 0,2 ml; Carl Roth, Karlsruhe, Germany) were used in all PCRs.
Six lysines located in the FhuA Δ1-160 channel were substituted by alanine using QuikChange (developed by Stratagene; La Jolla, CA, USA) [
Primers used for Site Directed Mutagenesis (SDM)
| Sequence Name | Sequence 5' to 3' |
|---|---|
| FhuA Δ1-160 K167A Fwd | CCGCTGAAAGAAGTTCAGTTTGCGGCCGGTACTGACAGCC |
|
|
|
| FhuA Δ1-160 K167A Rev | GGCTGTCAGTACCGGCCGCAAACTGAACTTCTTTCAGCGG |
|
|
|
| FhuA Δ1-160 K344A Fwd | GGCCATTATCTGGCACGTGCGTACGTCGTTGATGATGAGAAG |
|
|
|
| FhuA Δ1-160 K344A Rev | CTTCTCATCATCAACGACGTACGCACGTGCCAGATAATGGCC |
|
|
|
| FhuA Δ1-160 K364A Fwd | GATACCCAGTTGCAGAGCGCGTTTGCCACTGGCGATATCG |
|
|
|
| FhuA Δ1-160 K364A Rev | CGATATCGCCAGTGGCAAACGCGCTCTGCAACTGGGTATC |
|
|
|
| FhuA Δ1-160 K537A Fwd | GCAGTATGAAGTCGGCGTGGCGTATGTACCGGAAGATCG |
|
|
|
| FhuA Δ1-160 K537A Rev | CGATCTTCCGGTACATACGCCACGCCGACTTCATACTGC |
|
|
|
| FhuA Δ1-160 K556A Fwd | GCCGTGTATAATCTCACTGCGACCAACAACCTGATGGCGG |
|
|
|
| FhuA Δ1-160 K556A Rev | CCGCCATCAGGTTGTTGGTCGCAGTGAGATTATACACGGC |
|
|
|
| FhuA Δ1-160 K586A Fwd | CGTAGAAATCGAAGCGGCGGCGGCGCTGTCGGCGAG |
|
|
|
| FhuA Δ1-160 K586A Rev | CTCGCCGACAGCGCCGCCGCCGCTTCGATTTCTACG |
The SDM was performed by using a two-stage PCR protocol [
FhuA Δ1-160 variants were expressed, extracted and purified as previously described [
DMSO containing 3-(2-pyridyldithio) propionic acid N-hydroxysuccinimide ester (250 μl, 38 mM) was added drop-wise into FhuA Δ1-160 (750 μl, 4.3 μM) in phosphate buffer (pH 7.4, 0.2 M Na2HPO4, 0.2 M NaH2PO4, 3% oPOE) and stirred (1 h, 3000 rpm, RT//RCT basic IKAMAG, IKA-Werke GmbH, Staufen, Germany). Final concentration of DMSO and oPOE in the solution was 25% and 1.5%, respectively. The latter solution was used for formation of nanocompartments loaded with HRP (2.9 U/ml).
The film hydration method coupled with the mechanical dispersion technique by filter extrusion was used [
TMB (Sigma Cat. N°: T 0440) assay was selected as a conversion reporter system. Pre-prepared TMB/H2O2 solution were used in the kinetic measurement of the TMB oxidation by the HRP [
The authors declare that they have no competing interests.
AG carried out design and performed study, data analysis and drafting of the manuscript. MF and BH performed data analysis and drafting the manuscript. US carried out design, study and drafting of the manuscript. All authors read and approved the final manuscript.
Click here for file
We thank BASF AG ( Dr. Thomas Friedrich) and the State of Bremen (SfBW award FV 161) for financial support.